R. Hehlmann
- Hematology top 10%
- Oncology top 10%
- Viral-associated cancers and disorders 7
- Genetics top 10%
- Virus-based gene therapy research 4
-
- T-cell and Retrovirus Studies 6
- Animal Science and Zoology top 10%
- Animal Virus Infections Studies 3
-
- Chromosomal and Genetic Variations 4
-
- Parvovirus B19 Infection Studies 3
-
- Herpesvirus Infections and Treatments 3
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- S. SpiegelmanDonald KüfeWilliam G. BaxtJan HastkaChristine Leib‐MöschA SchwarzbeckM. StrauchVolker Erfle
- Cited by
- HematologyOncologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Blood (2 papers)Cytopathology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
R. Hehlmann
30 papers receiving 759 citations
Peers
Comparison fields: 5 of 75
- Hematology 135
- Oncology 326
- Genetics 94
- Immunology 169
- Animal Science and Zoology 77
Countries citing papers authored by R. Hehlmann
This map shows the geographic impact of R. Hehlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hehlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hehlmann more than expected).
Fields of papers citing papers by R. Hehlmann
This network shows the impact of papers produced by R. Hehlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hehlmann. The network helps show where R. Hehlmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Hehlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 35 | |
| 2 | 2004 | 51 | |
| 3 | 2004 | 29 | |
| 4 | Transcription of HERV-K-related LTRs in human placenta and leukemic cells. | 1994 | 17 |
| 5 | 1992 | 37 | |
| 6 | Endogenous retroviral elements in human DNA. | 1990 | 72 |
| 7 | Zusammenstellung der gebräuchlichen Definitionen und Klassifikationssysteme bei HIV-Infektion | 1989 | 2 |
| 8 | 1989 | 2 | |
| 9 | [Epidemiology of HIV infection]. | 1988 | 1 |
| 10 | Human endogenous retroviruses. | 1988 | 4 |
| 11 | 1978 | 5 | |
| 12 | [The mode of transfer of RNA tumor virus-like particles in melanomas]. | 1978 | 1 |
| 13 | 1978 | 3 | |
| 14 | 1975 | 34 | |
| 15 | [RNA-tumor-virus-like particles in human melanomas with specific relationship to a melanoma virus in mice]. | 1975 | 1 |
| 16 | Evidence for RNA tumor viruses in human lymphomas including Burkitt's disease. | 1973 | 24 |
| 17 | 1973 | 47 | |
| 18 | 1972 | 64 | |
| 19 | 1972 | 67 | |
| 20 | 1972 | 114 |
About R. Hehlmann
R. Hehlmann is a scholar working on Immunology, Genetics, Oncology, General Social Sciences and Animal Science and Zoology, having authored 30 papers that have together received 859 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (7 papers), T-cell and Retrovirus Studies (6 papers), Virus-based gene therapy research (4 papers), Chromosomal and Genetic Variations (4 papers), Parvovirus B19 Infection Studies (3 papers), Animal Virus Infections Studies (3 papers), Herpesvirus Infections and Treatments (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (135 citations), Oncology (326 citations), Genetics (94 citations), Immunology (169 citations) and Animal Science and Zoology (77 citations). R. Hehlmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include S. Spiegelman, Donald Küfe, William G. Baxt, Jan Hastka, Christine Leib‐Mösch, A Schwarzbeck, M. Strauch, Volker Erfle, Ruth Brack‐Werner and Thomas Werner. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood, Cytopathology, Cancer Chemotherapy and Pharmacology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.